Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Vaxfab Enterprises approved the Draft Directors' Report for FY ending March 31, 2025 and scheduled the 42nd Annual General Meeting for September 30, 2025, with e-voting from September 27–29, 2025. It approved increasing the authorised share capital from Rs. 9 crore to Rs. 35 crore, subject to shareholder approval. The board also approved issuing 2,54,94,763 fully convertible warrants at Rs. 21.02 per warrant on a preferential basis to public investors, aggregating to about Rs. 53.59 crore. It cleared the acquisition of three entities — Aarsha International Limited, Satvat Agro LLP, and Eklingji Tradelink Private Limited — to make them wholly owned subsidiaries via cash consideration, expected within 6 months. Additionally, M/s. V K Nagar & Associates was appointed as Internal Auditor for FY 2025-26, and Ms. Julee Miteshkumar Sanghavi was appointed as Company Secretary and Compliance Officer.
Shareholders can expect potential dilution from the warrant issue (up to ~2.55 crore shares) and a sharp scale-up in revenue base from the three acquisitions, which together had FY25 provisional turnover of roughly Rs. 28 crore. The preferential issue and capital expansion suggest the company is raising fresh equity to fund inorganic growth, which is a meaningful corporate restructuring event for the stock.